Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Gastric Carcinoma”

273 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 273 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05541146
What this trial is testing

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Who this might be right for
Gastric CancerPeritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo 30
Large-scale testing (Phase 3)Study completedNCT01839773
What this trial is testing

Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer

Who this might be right for
Stage IV Gastric Cancer
Daehwa Pharmaceutical Co., Ltd. 238
Testing effectiveness (Phase 2)Study completedNCT00003862
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer

Who this might be right for
Gastric Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)UnknownNCT01542294
What this trial is testing

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 71
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00020787
What this trial is testing

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)UnknownNCT00134095
What this trial is testing

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

Who this might be right for
Gastric Cancer
Fukushima Medical University Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT00448682
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery

Who this might be right for
Gastric Cancer
University of Miami 25
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT04220827
What this trial is testing

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Who this might be right for
Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT03755440
What this trial is testing

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Who this might be right for
Gastric Cancer Stage IVEBV
Sun Yat-sen University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07070466
What this trial is testing

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Who this might be right for
Stomach Cancer Stage IVEsophagus CancerStomach Cancer
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT01123473
What this trial is testing

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC 29
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Ended earlyNCT01748851
What this trial is testing

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Carcinoma Stage IV
Dong-A University Hospital 42
Load More Results